Penta Faculty

Adilia Warris

I am the editor-in-chief for Medical Mycology Case Reports and I have published over 200 peer-reviewed papers. I was awarded the Bill Marshall Award by the European Society for Paediatric Infectious Diseases in 2021. 

Adriana Paixão

I am a specialist in paediatric infectious diseases and work at the Institute of Pediatric Oncology of Federal University of Sao Paulo, Sao Paulo, Brazil.

My main research lines are the diagnosis and treatment of infectious diseases in paediatric oncology patients and those undergoing bone marrow transplantation.

Alasdair Bamford

I am a consultant and specialty lead in paediatric infectious diseases at Great Ormond Street Hospital, London, UK and an Honorary Associate Clinical Professor at the UCL Great Ormond Street Institute of Child Health, London, UK. I also work as a clinical advisor to paediatric clinical trials and cohort studies at the MRC Clinical Trials Unit, London, UK. I have over 15 years of experience in working with children, adolescents and families affected by HIV. I am one of the lead authors for the Penta/EACS guidelines for treatment of paediatric HIV infection, and a contributing author to the British HIV Association (BHIVA) guidelines on management of HIV in pregnancy.

I am a member of the Penta Scientific Committee and the UK Infectious Diseases in Pregnancy Screening Clinical Expert Review Panel. I am secretary of the British Paediatric Allergy Infection and Immunity Group (BPAIIG). I am also a regular faculty member for both online and residential PentaTr@ining courses on paediatric HIV in Europe, Africa, Asia and Russia.

Alexandra Compagnucci

I am a medical training at Facultad de Medicina, Buenos Aires University, trained in adult Infectious Diseases at Hospital Muñiz, Buenos Aires. I was part of one of the 2 pioneer groups in taking care of the first cases of HIV patients and has been involved in numerous training programmes on HIV across the country. I am also Head of the Haemophilic Cohort at the Haemophilia Foundation (established by. Dr. A. Pavlovsky), Haematology Research Institute, and National Medical Academy, taking care of HIV infection and co-morbidities, until I left the country to continue related activities in Paris, France. There I work at the Neumology Department at Hôtel-Dieu Hospital, responsible for the follow-up and treatment of HIV patients. Also member of the Penta Scientific Committee, the teaching staff of the Tr@inforPedHIV programme through the Penta ID network and one of the leaders of this programme in Latin America, together with the Spanish and Latin American colleagues. I’m involved in many International paediatric projects that include sites in all Continents, mainly focused on HIV in paediatrics.

Alla Volokha

I am a Doctor of Medicine and Professor of Paediatric Infectious Diseases and Paediatric Immunology in Shupyk National Medical Academy of Postgraduate Education, Kiev. Since 1992 I have been working in the field of infectious diseases in children and congenital immunodeficiencies – since 2000 in the field of HIV. I am also author of 135 scientific papers, including 2 textbooks, and member of paediatric societies ESPID (since 1997) and ESID (since 2002). I’ve been a lecturer on Penta courses on HIV infection since 2013. My priority areas of work are: HIV infection, congenital immunodeficiencies, vaccination.

Andreas H Groll

I am Professor of Paediatrics, Head of the Infectious Disease Research Programme and Deputy Director of the Department of Haematology/Oncology at the University Children’s Hospital in Münster, Germany.

My postgraduate education included fellowships in Infectious Diseases at the Children’s Hospital in Boston, and in Paediatric Haematology/Oncology at the National Cancer Institute in Bethesda, Maryland. I am board certified in Paediatrics, Paediatric Haematology/Oncology, and Infectious Diseases.

My research interests include infectious complications in the immunocompromised host, particularly invasive fungal infections, the pharmacokinetics and pharmacodynamics of antimicrobial agents, and the design and conduct of clinical research studies. I am a member of several international medical societies, on the editorial board of several international journals and have published more than 300 scientific articles thus far. I am regularly engaged in patient care as Attending Physician of the inpatient and outpatient service and the haematopoietic stem cell transplant program.

Andy Prendergast

I have graduated in medicine from Cambridge University and Imperial College London, and undertook my paediatric training in London, specializing in paediatric infectious diseases and immunology. After undertaking my DPhil in Oxford, investigating immunological and clinical aspects of paediatric HIV infection, I was a Lecturer in the Department of Paediatrics, University of Oxford, where I continued research into paediatric HIV infection and started work on clinical trials of HIV strategies in Africa through the MRC Clinical Trials Unit, London. I am currently a Wellcome Senior Clinical Fellow and Professor of Paediatric Infection and Immunology at Queen Mary University of London. For the past decade, I have been based in Zimbabwe, where I am the Director of the Zvitambo Institute for Maternal and Child Health Research. My interests lie in the interactions between infection, immunity and malnutrition, particularly in the context of HIV infection. My research group works on the mechanistic understanding of disease within pragmatic clinical trials, with a particular focus on maternal HIV, infant HIV, and children who are HIV-exposed and uninfected.

Anna Maria Geretti

Prof Anna Maria Geretti (MD, PhD, FRCPath) is a medical virologist with extensive experience in clinical, academic and pharmaceutical settings. In Italy, she is based at the Fondazione PTV, Tor Vergata University of Rome. In London, she is based at the North Middlesex University Hospital and is affiliated with the School of Immunity & Microbial Sciences of King’s College London. With over 300 publications, her research encompasses laboratory-based, patient-side, and epidemiological projects, including collaborations with the WHO and research work in Africa, with a focus on HIV and viral hepatitis. Anna Maria contributes to policy formulation, education and communication within several professional organisations, including as a member of the British HIV Association Guidelines Panel. Additionally, she serves as the Editor in Chief of the BMJ journal Sexually Transmitted Infections. Anna Maria is a passionate advocate for the advancement of healthcare and is deeply committed to training the next generation of clinicians and scientists. 

Anna Turkova

I am a research clinician at the Medical Research Council Clinical Trial Unit at UCL, London, and an Honorary Consultant Paediatrician at the Great Ormond Street Hospital. I am a Chief Investigator of the D3 trial, a multi-country randomised controlled trial comparing DTG/3TC vs. Standard of Care in virologically suppressed children and a trial physician in several large international paediatric HIV and TB trials and provide clinical input in epidemiological multi-centre studies.

I have been working with Penta since 2011, teaching on PentaTr@ining courses in Eastern and Western Europe, Russia, Central Asia and Africa. Moreover, I am a member of the Penta Antiretroviral Guidelines writing group (2015 – present), and a member of WHO HIV Guidelines Development Group, WHO-led Paediatric Antiretroviral Working Group (PAWG), Paediatric Antiretroviral Drug Optimisation (PADO) and Paediatric Hepatitis Working Group (PHWG).

Carlo Giaquinto

I am the President of Penta Foundation, full Professor of Paediatrics at the Department for Woman’s and Child’s Health of the University of Padova, and Director of the PhD Course in Developmental Medicine and Health Planning Sciences. My main interests are Paediatric Infections, Vaccinology and Clinical Trials in Children. Since 1990 I have been involved as scientific coordinator in more than 15 large EU funded projects. At present I coordinate more than 20 international projects, including trials in developing countries. I’m also the scientific leader of c4c, the largest paediatric IMI2 funded project, aiming to set up a European Paediatric Clinical trial platform. I am the Author/Co-Author of more than 300 publications published in peer-reviewed and invited as speaker at about 400 conferences and international workshops across the world. I was also awarded by the European Society for Paediatric Infectious Diseases (ESPID) of the 2017 Bill Marshall Award.

Caroline Foster

I am consultant in Paediatric and Adolescent Infectious Diseases and HIV at Imperial College Healthcare NHS Trust, London, UK, with a special interest in the transitional care and longterm follow up of young adults with perinatally acquired HIV infection. My research interests include the long-term outcomes for adults born with HIV (bone health, malignancies, fertility) and characterization of the latent reservoir in paediatric HIV. Research/education/guideline development and lecturing includes BHIVA, CHIVA, HYPNET, CHIPS/+, AALPHI, Penta, EPIICAL and UNICEF. I am also the past founding chair of HYPNet (HIV Young Persons Network), a multidisciplinary forum advising on care of adolescents living with HIV in the UK. I’m a Penta ID Network Member and PENTA Faculty Member.

Chiara Rubino

I am a Consultant in Paediatric Hepatology at Meyer Children’s Hospital in Florence. I am particularly interested in viral hepatitis. 

I have been working with Penta since 2022 and I was the course co-lead ofthe PentaTr@ining 2022-2023 online course on viral hepatitis with Professor Giuseppe Indolfi.

Chishala Chabala

I am Lecturer at the University of Zambia, School of Medicine and Consultant Paediatrician at University Teaching Hospitals-Children’s Hospital in Lusaka, Zambia. Also a part-time tutor at the London School of Hygiene and Tropical Medicine distance learning programme in clinical trials. My main area of clinical focus and research is childhood tuberculosis, HIV/AIDS and child lung health. I am an investigator on several multinational collaborative paediatric clinical trials on paediatric tuberculosis, HIV and pneumonia. I also have been a member of the PENTA Faculty since 2011 and participated in Tr@inforPedHIV courses in Africa and India.

Claire Thorne

I am a Professor of Infectious Disease Epidemiology in the Population, Policy and Practice Research and Teaching Department, UCL Institute of Child Health, University College London, UK. My research is focused on infectious diseases epidemiology in relation to maternal and child health, and I have conducted research on HIV, viral hepatitis, syphilis, SARS-CoV-2 and Zika virus. I lead several cohort and surveillance studies on infections in pregnancy, including national surveillance of HIV, syphilis and hepatitis B infections in pregnancy and related outcomes in England. I lead the pregnancy component of the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC). My research goals include addressing key evidence gaps in order to improve the clinical management of pregnant women living with or at risk of high-consequence infections, and to delineate the risks and benefits of specific interventions, such as the use of antiviral therapies and vaccines.  

I am a Board Member of the Penta Foundation and a member of the Scientific Committee of the Penta Child Health Network. 

Daniele Donà

I’m Daniele, a pediatric infectious disease consultant at the Department of Women’s and Children’s Health at the University of Padua, Italy. My focus is on antibiotics and antimicrobial resistance, and I earned my PhD and MSc while implementing antimicrobial stewardship projects and designing clinical trials of antibiotics in neonates and children. I’m passionate about refining clinical judgment and optimizing treatment to reduce unnecessary prescriptions, adverse events, and healthcare costs associated with antimicrobial resistance.

During the COVID-19 pandemic, my research interests also included the impact of SARS-CoV-2 on pediatric patients, with particular attention to the immunological and serological response. I’m convinced of the growing need for pediatric infectious disease specialists, and I aim to make a tangible impact on patient health while advancing the field’s knowledge and practices.

David Burger

I received my Pharmacy Degree at the Utrecht University in 1990 and completed my PhD. After this, I moved to the Radboud University Medical Centre, Nijmegen, for my hospital pharmacist training. From 1997 to 2005, I worked as a Hospital Pharmacist Responsible for the coordination of clinical trials conducted at the Radboud University Medical Centre. Since 1997 I have been leading a research group focusing on clinical pharmacology of antimicrobial agents with emphasis on HIV, TB, fungal infections, and HCV. He is member of the Editorial Board of the and websites on behalf of the European AIDS Clinical Society. I’m also a member of the Organizing Committee of the annual International Workshop on Clinical Pharmacology of HIV/Hepatitis Therapy and is on the panel for HIV treatment guidelines of the IAS-USA. I’m the (co-)author of more than 300 publications in this field. My topics of interest are drug-drug interactions, paediatric pharmacology, therapeutic drug monitoring, and operational research in resource-limited countries. I’m a Penta ID Network Member and Penta Faculty Member.

Diana “Di” Gibb

I am a Paediatrician, Professor of Epidemiology and has been Programme Leader of the Paediatric Programme of trials and cohorts at the MRC Clinical Trials Unit at University College London.

I am a founding Member of the Penta Network, focusing on design and execution of clinical trials and cohorts. These started in Europe and then enlarged to Asia and South America.

Capacity development is an important feature of my overseas collaborations, including initiating and leading PentaTr@ining programmes in African and Asian centres, on-the-ground training in clinical trials and PhD mentorship. I have served on a number of WHO advisory and guideline committees. In 2018, the CHAPAS trials teams, which I lead, was awarded outstanding African Research Team by EDCTP. I was also awarded an honorary doctorate from the University of York for her work in global child health in 2019 and was made a Fellow of the Academy of Medical Sciences in 2020.

Eiman Alblooshi

I am a paediatric infectious diseases consultant at Tawam hospital. A tertiary healthcare facility and a teaching hospital in Abu Dhabi, United Arab Emirates.  

I had my fellowship training in Infectious Diseases in Durban, South Africa and I obtained my sub-specialty certificate from the College of Medicine of South Africa in 2022.  

My special interests include: infections in immunocompromised hosts and HIV, antimicrobial resistance and antimicrobial stewardship. 

I am a member of several local and international medical societies.  

Working across different cultures is my passion. I’m actively involved in academic teaching and medical education, locally, regionally, and internationally. 

Emmanuel Roilides

I am Professor of Paediatrics-Infectious Diseases in Aristotle University School of Medicine at Hippokration General Hospital in Thessaloniki, Greece. I am Fellow of European Confederation of Medical Mycology as well as of European Society of Clinical Microbiology and Infectious Diseases, member of the Steering Committee of European Paediatric Mycology Network (EPMyN) and very close collaborator of Penta. My research focuses on fungal infections and multi-resistant Gram-negative bacteria. I am on the Editorial Board of several international biomedical journals and author of >660 peer reviewed articles and book chapters with >14000 citations. I have been co-ordinator or partner in several multicentre or multinational studies.

Gareth Tudor-Williams

I am an Emeritus Professor of Paediatric Infectious Diseases at Imperial College London, having retired as a Consultant in PID at Imperial College Healthcare NHS Trust, St. Mary’s Hospital, London in September 2021.  

After working in Nepal for Save the Children Fund UK, 1982-84, I later specialised in HIV infection in children, training for 5 years in the USA at Duke University and the NIH, Bethesda, MD. From 1994-2021 I was a member of the PID group at Imperial College London, involved in international Phase II and III trials relating to paediatric blood-borne virus infections. I was the founding Chair of CHIVA (Children’s HIV Association of the UK and Ireland). 

In semi-retirement, I am chair of the Penta Network Engagement Committee, and am a Visiting Professorship at Chulalongkorn University, Bangkok, Thailand. I also chair the London Central Research Ethics Committee for the Health Research Authority UK. 

George Abongomera

George Abongomera, MD, MSc, PhD, is a physician and researcher working as a Clinical Specialist, Digital Health Unit at the Swiss Centre for International Health of the Swiss Tropical and Public Health Institute. In this role he develops clinical algorithms for their digitalisation into Clinical Decision Support Systems for low and middle income countries (LMIC). He is responsible for monitoring and evaluation of these systems, training of clinicians how to use these systems and engagement with the local ministries of health. Prior to joining the Swiss TPH, he was working at the University of Zurich as Group leader for the Sub-Saharan Africa programs in the public and global health department at the Epidemiology, Biostatistics and Prevention Institute (EBPI). Furthermore, he spent eleven years managing HIV prevention, care and treatment projects and programs in Sub-Saharan Africa. During this period, he had PhD training at the University of Antwerp in Belgium, his work focused on decentralisation of antiretroviral treatment (ART) and care to rural primary health centres in Uganda, Malawi and Zimbabwe. He successfully managed teams within a matrix environment to demonstrate that it was safe and feasible to initiate HIV treatment in lower level health facilities in rural communities where patients had to walk long distances to access ART. 

Giuseppe Indolfi

I am a consultant in pediatric hepatology and serve as the clinical lead for the service at the Meyer Children’s University Hospital of Florence. My research primarily focuses on various aspects of viral hepatitis, ranging from vertical transmission to treatment. On the clinical side, I oversee the care of children with all types of liver diseases, including congenital conditions. I have participated in various trials related to the treatment of hepatitis C virus infection using direct-acting antivirals, and I have conducted real-world studies to validate the effectiveness of these new drugs in everyday clinical practice. Additionally, I have served as a consultant for the World Health Organization and I am a member of Penta-ID and serve as the coordinator of PENTAHep, a consortium of pediatric hepatologists and infectious disease specialists established in 2012. PENTAHep integrates the expertise accumulated by PENTA over nearly 25 years with the necessity for new research in paediatric viral hepatitis.

Greta Miño León

I am Director of the Paediatric Infectious Diseases Service at the Children´s Hospital Dr. Francisco de Icaza Bustamante, Guayaquil, Ecuador. Also part of the teaching staff of the Paediatric European Network Treatment of AIDS (PENTA) “Tr@inforPedHIV” Programme for Latin America and the Caribbean (2008 – 2019). I was Consultant for National HIV Program, Ministry of Health (1998 – 2018). I have been the past President of the Latin American Pediatric Infectious Disease Society, since 2011. I’m a Member of the European Society Paediatric Infectious Disease (ESPID); Member of the Pediatric Infectious Disease Society of America; Member of the Latin American Pediatric Infectious Disease Society. I’ve been involved in International paediatric projects and research, including on the Zika virus.

Guido Castelli

I am Chief of Vaccination Unit – University-Hospital department, University of Tor Vergata and Paediatric hospital Bambino Gesù – Rome; Lecturer of infectious diseases at the Nursing School of Tor Vergata University – Rome; President of the Italian Society of Paediatric Infectious Diseases. I was teacher of infectious diseases at the School of Specialization in Paediatrics of Tor Vergata University – Rome.  I’m also Member of the Penta Scientific Committee and Member of the Steering Committee of the Italian Register for HIV infection in children. I am the author and co-author of about 200 papers in National and International Scientific Journals.

Gwamaka Mwasakifwa

I am an HIV physician and clinical researcher with over eight years of experience in HIV medicine, particularly adolescent HIV treatment.  He is currently based at the Kirby Institute, University of New South Wales. His current research examines the use of biological markers in predicting HIV associated comorbidities in low and middle-income countries.

He has previously worked in HIV and TB care and treatment services in Tanzania, and Nepal. He has been involved in the Tr@inforPedHIV training courses since 2016.  He has a keen interest in developing intelligent clinical tools, and innovative digital health solutions focused on improving patient experiences, quality of care, service delivery and strengthening global health systems.

Hermione Lyall

I am a consultant in paediatric infectious diseases and clinical lead for the service at Imperial College Healthcare NHS Trust, London. Prevention of transmission of HIV from mother to infant, and management of HIV infected children and young people are my main areas of clinical work. I also look after children with other congenital infections (syphilis, toxoplasmosis, CMV etc) and work with the multidisciplinary team to promote their prevention. I run a weekly congenital infection clinic and am involved in setting up a European registry for congenital CMV infection. I am a member of the Penta Scientific Committee and participate in treatment trials for HIV infected children. I am passionate about sharing experience with clinical colleagues, and learning together about our patients’ conditions and how to care for them better.

In 2005, we initiated ‘Tr@inforPedHIV’, a unique online and residential course for paediatric HIV. Now called ‘PentaTr@ining’, this course has trained more than 4,000 healthcare workers around the world on the management of paediatric HIV.

Hylke Waalewijn

I finished my training as a pharmacist in February 2017 and currently I’m in my PhD trajectory in the research group of David Burger at the Radboud Institute for Health Sciences in Nijmegen, The Netherlands. My research focuses on the pharmacokinetics of antiretroviral drugs, specifically in HIV infected children. Currently, I am involved in the CHAPAS-4 and Odyssey projects. I also have been involved in the Tr@inforPedHIV training courses since 2017. My interests include: global health, pharmacokinetics (in paediatrics), and pharmacometrics.

Justin Penner

I am currently a paediatric infectious diseases consultant at the Children’s Hospital of Eastern Ontario in Ottawa, Canada. After completing my paediatric training at the University of Manitoba in Winnipeg, Canada with a special focus in infectious diseases, I went on to work in paediatric infectious disease at Imperial College Healthcare Trust where my interest in congenital infections grew through outstanding mentorship from the paediatric infectious diseases group at St Mary’s Hospital, London. This experience further expanded on my previous work with congenital syphilis in the Canadian north and arctic. I went on to work as the senior clinical fellow in paediatric infectious diseases at Great Ormond Street Hospital Im London,UK.

Throughout my training, I have also completed an MSc in ‘Tropical Medicine and International Health’ at the London School of Hygiene and Tropical Medicine. My area of research concentrates on diseases that affect marginalised indigenous populations of the circumpolar region where maternal-foetal diseases, often of infectious aetiology still remain prominent.

I am very excited to be part of the expanded PentaTr@ining 2024 programme, which now includes a widened curriculum of congenital infections, HIV and beyond.

José Tomás Ramos

I have a Medicine degree: Universidad Complutense of Madrid, with Specialization in Paediatrics, Sub-speciality Infectious Diseases. I’m a Consultant in Paediatric Infectious diseases at the Section of Immunodeficiencies, Department of Paediatrics in Hospital 12 Octubre, Madrid. I have been Head of Pediatrics University Hospital Getafe, since 2006. Principal Investigator of 21 investigational projects, most on HIV-infection in children. Principal investigator of the Madrid cohort of HIV-infected children and the Madrid cohort of HIV infected mother-infant pairs. Author and co-author of 78 book chapters, and 214 publications; reviewer of several international and Spanish journals on Paediatrics and Infectious Diseases. Also Member of the Penta Scientific Committee since 1998, and Member of the Spanish Advisory Committee of Plan Nacional del SIDA (Ministry of Health) since 2000.

Laura Marques

I am a Medical Doctor since 1986, and a Consultant in Paediatrics since 2001 in the Paediatricc Department of Centro Materno-Infantil do Norte – Centro Hospitalar Universitário do Porto. 

I’m the Coordinator of Unidade de Infeciologia e Imunodeficiências do Serviço de Pediatria do Centro Materno-Infantil do Norte – Centro Hospitalar Universitário de Santo António, in Porto, Portugal, Member of Unidade de Imunologia Clínica do Centro Hospitalar Universitário de Santo António; Head of Hospital de Dia de Pediatria do Centro Materno-Infantil do Norte, Founding Member of Sociedade de Infeciologia Pediátrica da SPP and of the Portuguese Paediatric HIV Working Group. 

I am member of Penta since 2007. I worked in Penta’s Steering Committee for many years,  was PI of several PENTA clinical trials in Porto as KONCERT, SMILE and ODYSSEY.  

I am part of the PentaTr@ining team and have been lecturing in several Penta formations, in presence and online for the past 10 years. I have also been involved in the organisation of Penta Aperitivo sessions. 

Luba Okhonskaia

I am PhD and I work as an Infectious Diseases Consultant in the Republican Clinical Infectious Diseases Hospital of the Ministry of Health of Russia, Saint Petersburg, since 2011. I have been teaching on Penta Tr@ining Courses in Eastern Europe and Central Asia since 2014 and has been one of the leading tutors on the online Russian course. My current interests are HIV infection, HIV/TB coinfection and viral hepatitis in children and adults.

Luis Castaneda

I am a medical doctor, specialised in the field of Paediatrics. I collaborate in different International Organizations in the area of paediatric HIV and congenital Syphilis, I am past president of the Pediatric Association of El Salvador and also international member of the American Academy of Pediatrics (AAP) since 2000. I currently work as coordinator of the Centro de Excelencia para Ninos con Inmunodeficiencia, Hospital Nacional de Ninos “Benjamin Bloom”, a national centre for treatment of paediatric AIDS in El Salvador, I was involved in the implementation of the PMTCT program in El Salvador and now part of the EMTCT strategy. I am involved in several projects involving Paediatric HIV in the region as part of a regional network of paediatric HIV in Latin America “PLANTA”.

María José Mellado Peña

I am Head of Department: General Paediatrics, Infectious and Tropical Diseases-Vaccination at Universitary Hospital La Paz, Madrid. Spain. CSUR- National Reference Spanish Centre on Paediatric Tropical Diseases from Health Ministry. I’m also Associate Professor of Madrid Autónoma University, and European Paediatric Translational Research Infrastructures. I’m part of the Penta Scientific Committee and Penta Tr@ining.

Marinella Della Negra

I have worked as a Principal Investigator in over 40 Phase II, III and IV studies with children and adults infected with HIV since 1994, leading to extensive experience in clinical trials with new drugs and / or new treatments for HIV disease.

I was the President of an inpatient unit at the Institute of Infectious Diseases Emilio Ribas, a reference Hospital for medical care, medical education and medical research for undergraduate, graduate and scholarship programmes.

I was also a Professor of Infectious Diseases at the School of Medical Sciences of Santa Casa de São Paulo, Brazil, one of the three best medical schools in São Paulo. I’ve been President of an NGO called Association of Assistance to Children and Adolescents with HIV since 1989, and had the role of assisting children, adolescents and their families. I am a Consultant of the HIV Advisory Committee of the Ministry of Health of Brazil.

Mark Cotton

I am Head of Division of Paediatric Infectious Diseases and Director of the Family Infectious Diseases Clinical Research Unit at Tygerberg Children’s Hospital (TCH), Stellenbosch University (SU). I then undertook a Fellowship in paediatric infectious diseases at University of Colorado between 1991 and 1995. I’m also affiliated to the IMPAACT and Penta Networks and provided technical support for WHO initiatives since 2004 on the Classification for HIV, antiretroviral guidelines and TB-HIV co-infection. I’m most interested in HIV cure and remission and how to do this in children. I’m the principal investigator for the SU Clinical Trial Unit (SUN-CTU) with special focus on tuberculosis and HIV, and I’m involved in TB vaccine studies including a recombinant BCG vaccine. I have also recently re-engaged in antimicrobial resistance, which is an expanding threat to children with fewer resources than the early years of the HIV pandemic.

Marta Vasylyev

Marta Vasylyev is working as an infectious diseases specialist at Astar Medical Center in Lviv, Ukraine, and is a PhD candidate at Erasmus MC, Rotterdam, the Netherlands. 

Together with Dr.Casper Rokx and an HIV specialist united by the European AIDS Clinical Society (EACS) as Young Investigators (YING), she is cofounder of Ukraine 

Dr.Vasylyev is a member of the Governing Board of the European AIDS Clinical Society (EACS) and member of the Guidelines Treatment Panel. 

Mary Hepburn

I was trained first as a General Practitioner, then as an Obstetrician and Gynecologist. I established and, for 30 years until my retirement from clinical practice in 2014, was consultant in charge of the Glasgow Women’s Reproductive Health Service, (WRHS) a city-wide service for women with social problems. WRHS was the regional service providing reproductive healthcare for women infected with or affected by bloodborne viruses including HIV and HCV. I retired from clinical practice in 2014, but continue non-clinical work including teaching (undergraduate and postgraduate), training and support for service development nationally and internationally. 

Moherndran Archary

I am a Paediatric Infectious Disease Specialist in the Department of Paediatrics and Child Health at King Edward VIII Hospital affiliated to the Nelson R Mandela School of Medicine, University of KwaZulu-Natal. I’m actively involved with the management of children and adolescents with HIV both locally and nationally within South Africa. My research interests include antiretroviral drug therapeutics, viral resistance and optimal timing of initiation of antiretroviral therapy in the developing world.

Mutsa Bwakura

I am a Consultant Paediatrician and Senior Lecturer within the department of Paediatrics and Child Health at the University of Zimbabwe College of Health Sciences. I have served as the Project Leader for the ARROW and REALITY Clinical Trials, and also affiliated to the IMPAACT network where I have been site Principal Investigator for a number of clinical trials in children including ART strategies for children. I am currently a Wellcome Trust Training Fellow where my research is focusing on the long term outcomes of severely malnourished HIV-infected and HIV-uninfected children following discharge from hospital.

Nelesh Govender

I am a medical doctor with specialist pathology training in clinical microbiology. I am also a trained medical mycologist and epidemiologist. I work as a centre head at the National Institute for Communicable Diseases in Johannesburg, South Africa where I run the national mycology reference laboratory. A major theme of my public health-focused mycology research is HIV-associated fungal diseases, many of which are life-threatening. My research activities span laboratory science including characterisation of established and emerging fungal pathogens and diagnostic test development and evaluation; population-based observational epidemiological studies; cost-effectiveness modelling of public health interventions and treatments; and clinical trials. My academic affiliations are with the University of the Witwatersrand, University of Cape Town, University of Exeter and St George’s University of London. I am a member of the Penta Fungal Infections Working Group.

Pablo Rojo

I am a Paediatric Infectious Diseases Specialist of Hospital 12 de Octubre, Madrid, Spain, and also Professor of Pediatrics at Complutense University, Madrid, Spain. I obtained my MD and PhD from Complutense University. I’m author and co-author of over 80 peer reviewed scientific articles and book chapters. My main research activities are related to pediatric HIV, S. aureus and congenital CMV infection. I am a Member of the Penta Network and have been part of the PentaTr@ining program for the past 10 years. I’ve participated in many paediatric antiretroviral clinical trials and is part of the EPIICAL project pursuing novel therapeutics approaches for early treated HIV-infected children. I’m also co-Chief Investigator of ODYSSEY and Chief Investigator of the EMPIRICAL trial. 

Pere Soler Palacín

I am a paediatric immunologist, specialist in paediatric infectious diseases and head of the Paediatric Infectious Diseases and Immunodeficiencies Unit at Hospital Universitari Vall d’Hebron, Barcelona, Catalonia, Spain. I am the Director of the Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies (Barcelona) and the local coordinator of the European Reference Network for Immunodeficiencies (ERN-RITA) site in Barcelona.

My main research lines are the diagnosis and treatment of primary immunodeficiencies and the optimization of pharmacokinetic parameters of anti-infectives in pediatrics.

I have authored more than 200 publications in indexed journals and more than 200 communications in national and international scientific meetings.

I am an associate Professor of Paediatrics at the Universitat Autònoma de Barcelona (UAB) since 2010 and director of the Master in Paediatric Infectious Diseases at the UAB.

Peter Olbrich

I obtained my MD from the Philipps University in Marburg (Germany) and my PhD from the University of Seville in Spain. From 2014-2018 I served as the Chair of the ESID Junior Working Party. I currently hold a tenure track position funded by the Instituto de Salud Carlos III (Juan Rodés), which allows me to combine clinical care as well as experimental research activities. I am a consultant for paediatric immunology and infectious diseases at the Hospital Virgen del Rocio, Seville, Spain and co-principal investigator of the Inborn errors of immunity research group under the lead of Dr O Neth at the Institute of Biomedicine in Seville.

My main research interests are primary and secondary immunodeficiencies focusing on the understanding and modulation of underlying mechanisms aiming to identify the best possible treatment options for each patient. I am associate Professor at the Department of Pediatrics at the University of Seville and coordinator of the “invasive fungal infections” working group of the Sociedad Española de Infectología Pediátrica.

Rashida Ferrand

I am an HIV Clinical specialist and an epidemiologist. I’m also a Wellcome Trust Senior Clinical Fellow and a Professor of International Health at the London School of Hygiene and Tropical Medicine. I’m based in Zimbabwe where I direct the Zim-LSHTM Research Partnership. My research focuses on developing and evaluating strategies to improve outcomes across the HIV cascade in adolescents and young people. The other main area of research focus is the long-term chronic comorbidities associated with HIV infection among children growing up with HIV, specifically respiratory cardiac and musculoskeletal disease.

Steve Welch

I am a Consultant in Paediatric HIV and Paediatric Infectious Diseases at Heartlands Hospital and Birmingham Chest Clinic, University Hospitals Birmingham. The UK’s buzzing Second City has the largest paediatric HIV and TB services in the UK. I’ve been part of Member of Penta Scientific Committee, 2009 onwards. I’m also the Training Lead for Penta since 2010 and for pTBnet since 2016.

Thomas Lehrnbecher

I am Professor of Pediatrics and since 2018 the Head of the Department of Pediatric Hematology/Oncology of the Johann Wolfgang Goethe-University, Frankfurt, Germany. I trained in the Children’s Hospital in Würzburg, Germany, and at the Pediatric Oncology Branch of the National Cancer Institute, Bethesda, USA. My clinical and laboratory research focuses on infectious complications in children with cancer, the development of immunotherapeutic strategies against invasive fungal infections in hematopoietic stem cell transplant recipients, and the interaction of host immune cells and fungi.

I currently chair the sections “Infection in the immunocompromised child” of both the German Society of Pediatric Infectious Diseases and the German Society of Pediatric Oncology and Hematology, and, until 2016, the working group “Supportive Care” of the International Society of Pediatric Oncology. Since 2018, I am a member of the international council of the Immunocompromised Host Society.

Tim Cressey

I have been actively involved in HIV clinical research studies for over 20 years, primarily focused on mother and child health. Since completing my PhD in pharmacology at Newcastle University in the UK in 2001, I have been working as a researcher at the PHPT-Clinical Trial Unit based at the Faculty of Associated Medical Sciences, Chiang Mai University, Thailand. I have performed multiple clinical pharmacokinetic studies in adults, adolescents, children, pregnant women and newborns. I’m also an active member of the Paediatric European Network for Treatment of AIDS (PENTA) and the NIH-funded International Pediatric Maternal Adolescent AIDS Clinical Trials (IMPAACT) network. I’m currently a Member of the World Health Organization convened Pediatric Optimization Working Groups on Antiretrovirals and Viral Hepatitis (PWGH). 

Tim Niehues

I’m the Director of the Centre for Child Health and Adolescence, HELIOS Klinikum Krefeld, Germany. 

I was trained at  the Children’s Hospital at Heinrich Heine University Hospital in Düsseldorf  and was a Postdoctoral Fellow in the Department of Molecular Medicine, North Shore University Hospital (NSUH), Cornell University New York.  

Since 2006, I am a Member of Penta Scientific Committee. I’m also a Professor of Paediatrics (Heinrich Heine University Düsseldorf), and  Co-author of Penta Guidelines for Treatment of children with HIV infection. 

Ton Noguera

I am a Consultant in Paediatric Infectious Diseases at Hospital Sant Joan de Déu in Barcelona (Spain), and a Professor of Paediatrics at Universitat de Barcelona and coordinates the Master Course in Paediatric Health (Hospital de Nens, Universitat de Barcelona) as well. I graduated from the Universitat de Barcelona in 1997 and completed my internship and residency in Paediatrics at Hospital Sant Joan de Déu in 2003. My areas of interest include: HIV and other vertically-transmitted infections and tuberculosis in the pediatric age. I’ve been part of the Penta Scientific Committee since 2010 and have given lectures in several Penta training courses on HIV infection in children and adolescents in Latin America.

Victor Musiime

I’m a Paediatrician in Uganda, and I work as an Associate Professor at Makerere University, College of Health Science, School of Medicine, Department of Paediatrics and Child Health. I also conduct research at Joint Clinical Research Centre (JCRC), mainly in Paediatric HIV, where I hold the position of Senior Research Consultant. At Makerere University, I conduct didactic and clinical sessions for undergraduate and postgraduate students, and supervises Masters and PhD research projects; and conduct research in various aspects of child health. My clinical and research interests are: Paediatric Infectious diseases, gastrointestinal disorders, childhood nutrition and other child health issues.

Vira Chechenieva

I have working as a Paediatrician in the Infectious Diseases Centre “Clinic for treatment of children with HIV/AIDS” at the National Specialized Children’s Hospital “OKHMATDIT”, Kyiv, Ukraine since February 2008. My duties are the examination, treatment and management of children with HIV and their parents. In the period from 2008 to 2010, as well as my work in the Clinic, I regularly went on working trips to different regions of Ukraine in order to consult with patients, monitor regional Centres for HIV/AIDS treatment. During the mentioned period, I also took part both in organizing and facilitating training programmes devoted to the problem of paediatric HIV for doctors, caregivers, and staff at orphanages.

In 2017 I worked as a Clinical advisor at the International training & education centre for health (I-TECH) / University of Washington in Ukraine under the international project “Strengthening Capacity of HIV/AIDS Treatment in Ukraine”.

Since 2018 I have worked as a Junior Researcher at the Paediatric Department of the National Institute of Phthisiology and Pulmonology.